The pharmaceutical company said it would start selling higher dosages of its Zepbound drug, known as tirzepatide, through Lilly Direct, its direct-to-consumer business. The new dosages – in 7.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback